Export 94 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is M  [Clear All Filters]
2022
G. J. Gorse, Grimes, S., Buck, H., Mulla, H., White, P., Hill, H., May, J., Frey, S. E., and Blackburn, P., “MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.”, Vaccine, vol. 40, no. 10, pp. 1472-1482, 2022.
D. R. Stevens, Rohn, M. C. H., Hinkle, S. N., Williams, A. D., Kumar, R., Lipsky, L. M., Grobman, W., Sherman, S., Kanner, J., Chen, Z., and Mendola, P., “Maternal body composition and gestational weight gain in relation to asthma control during pregnancy.”, PLoS One, vol. 17, no. 4, p. e0267122, 2022.
2020
T. F. C. Heeren, Chew, E. Y., Clemons, T., Fruttiger, M., Balaskas, K., Schwartz, R., Egan, C. A., and Issa, P. Charbel, “Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.”, Ophthalmology, 2020.
T. Winhusen, Lofwall, M., Jones, H. E., Wilder, C., Lindblad, R., Schiff, D. M., Wexelblatt, S., Merhar, S., Murphy, S. M., Greenfield, S. F., Terplan, M., Wachman, E. M., Kropp, F., Theobald, J., Lewis, M., Matthews, A. G., Guille, C., Silverstein, M., and Rosa, C., “Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.”, Contemp Clin Trials, vol. 93, p. 106014, 2020.
M. M. Harkenrider, Markham, M. Jennifer, Dizon, D. S., Jhingran, A., Salani, R., Serour, R. K., Lynn, J., and Kohn, E. C., “Moving Forward in Cervical Cancer - Enhancing Susceptibility to DNA Repair Inhibition and Damage: NCI Clinical Trials Planning Meeting Report.”, J Natl Cancer Inst, 2020.
L. A. Jackson, Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., Pruijssers, A. J., McDermott, A., Flach, B., Doria-Rose, N. A., Corbett, K. S., Morabito, K. M., O'Dell, S., Schmidt, S. D., Swanson, P. A., Padilla, M., Mascola, J. R., Neuzil, K. M., Bennett, H., Sun, W., Peters, E., Makowski, M., Albert, J., Cross, K., Buchanan, W., Pikaart-Tautges, R., Ledgerwood, J. E., Graham, B. S., and Beigel, J. H., “An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.”, N Engl J Med, 2020.
2019
L. Rooney, Covington, L., Dedier, A., and Samuel, B., “Measuring IRB Regulatory Compliance: Development, Testing, and Use of the National Cancer Institute StART Tool.”, J Empir Res Hum Res Ethics, vol. 14, no. 2, pp. 95-106, 2019.
M. Murti, Otterstatter, M., Orth, A., Balshaw, R., Halani, K., Brown, P. D., Hejazi, S., Thompson, D., Allison, S., Bharmal, A., Dawar, M., Hoyano, D., Lee, V., Naus, M., Pollock, S., Bevanda, J., Coughlin, S., Fitzgerald, J., Keen, D., Maracle, M., Sprague, S., and Henry, B., “Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada.”, Vaccine, vol. 37, no. 30, pp. 4008-4014, 2019.
M. Murti, Otterstatter, M., Orth, A., Balshaw, R., Halani, K., Brown, P. D., Hejazi, S., Thompson, D., Allison, S., Bharmal, A., Dawar, M., Hoyano, D., Lee, V., Naus, M., Pollock, S., Bevanda, J., Coughlin, S., Fitzgerald, J., Keen, D., Maracle, M., Sprague, S., and Henry, B., “Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.”, Vaccine, vol. 37, no. 30, pp. 4001-4007, 2019.
M. S. Ip, Oden, N. L., Scott, I. U., VanVeldhuisen, P. C., Blodi, B. A., Ghuman, T., and Baker, C. W., “Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study.”, JAMA Ophthalmol, vol. 137, no. 3, pp. 281-287, 2019.
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., and Chan, C. K., “Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial.”, JAMA Ophthalmol, 2019.
A. Nowak-Węgrzyn, Wood, R. A., Nadeau, K. C., Pongracic, J. A., Henning, A. K., Lindblad, R. W., Beyer, K., and Sampson, H. A., “Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy.”, J Allergy Clin Immunol, vol. 143, no. 2, pp. 651-661.e9, 2019.
K. L. Kotloff, Shirley, D. - A. T., C Creech, B., Frey, S. E., Harrison, C. J., Staat, M., Anderson, E. J., Dulkerian, S., Thomsen, I. P., Al-Hosni, M., Pahud, B. A., Bernstein, D. I., Yi, J., Petrikin, J. E., Haberman, B., Stephens, K., Stephens, I., Oler, R. E., and Conrad, T. M., “Mupirocin for Decolonization of Infants in Neonatal Intensive Care Units.”, Pediatrics, vol. 143, no. 1, 2019.
2018
O. D. Jarrett, Seward, J. F., Fombah, A. E., Lindblad, R., Jalloh, M. I., El-Khorazaty, J., Dawson, P., Burton, D., Zucker, J., Carr, W., Bah, M. M., Deen, G. F., George, P. M., James, F., Lisk, D. R., Pratt, D., Russell, J. B. W., Sandy, J. D., Turay, P., Hamel, M. J., Schrag, S. J., Walker, R. E., Samai, M., and Goldstein, S. T., “Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.”, J Infect Dis, vol. 217, no. suppl_1, pp. S24-S32, 2018.
2017
E. Shemesh, Bucuvalas, J. C., Anand, R., Mazariegos, G. V., Alonso, E. M., Venick, R. S., Reyes-Mugica, M., Annunziato, R. A., and Shneider, B. L., “The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study.”, Am J Transplant, vol. 17, no. 10, pp. 2668-2678, 2017.
D. R. Murdoch, Morpeth, S. C., Hammitt, L. L., Driscoll, A. J., Watson, N. L., Baggett, H. C., W Brooks, A., Knoll, M. Deloria, Feikin, D. R., Kotloff, K. L., Levine, O. S., Madhi, S. A., O'Brien, K. L., J Scott, A. G., Thea, D. M., Ahmed, D., Awori, J. O., DeLuca, A. N., Ebruke, B. E., Higdon, M. M., Jorakate, P., Karron, R. A., Kazungu, S., Kwenda, G., Hossain, L., Makprasert, S., Moore, D. P., Mudau, A., Mwaba, J., Panchalingam, S., Park, D. E., Prosperi, C., Salaudeen, R., Toure, A., Zeger, S. L., and Howie, S. R. C., “Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study.”, Clin Infect Dis, vol. 64, no. suppl_3, pp. S271-S279, 2017.
M. A. Minaya, Jensen, T. L., Goll, J. B., Korom, M., Datla, S. H., Belshe, R. B., and Morrison, L. A., “Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections.”, J Virol, vol. 91, no. 23, 2017.
B. L. Scott, Pasquini, M. C., Logan, B. R., Wu, J., Devine, S. M., Porter, D. L., Maziarz, R. T., Warlick, E. D., Fernandez, H. F., Alyea, E. P., Hamadani, M., Bashey, A., Giralt, S., Geller, N. L., Leifer, E., Le-Rademacher, J., Mendizabal, A. M., Horowitz, M. M., H Deeg, J., and Horwitz, M. E., “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.”, J Clin Oncol, vol. 35, no. 11, pp. 1154-1161, 2017.
2015
D. A. Hien, Campbell, A. N. C., Ruglass, L. M., Saavedra, L., Mathews, A. G., Kiriakos, G., and Morgan-Lopez, A., “Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.”, J Subst Abuse Treat, vol. 56, pp. 23-33, 2015.
D. A. Hien, Campbell, A. N., Ruglass, L., Saavedra, L., Matthews, A. G., Kiriakos, G., and Morgan-Lopez, A., “Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example”, J Subst Abuse Treat, vol. 56, pp. 23-33, 2015.
F. B. Sallo, Leung, I., Clemons, T. E., Peto, T., Bird, A. C., and Pauleikhoff, D., “Multimodal Imaging in Type 2 Idiopathic Macular Telangiectasia”, Retina, vol. 35, pp. 742-749, 2015.
F. B. Sallo, Leung, I., Clemons, T. E., Peto, T., Bird, A. C., and Pauleikhoff, D., “Multimodal imaging in type 2 idiopathic macular telangiectasia.”, Retina, vol. 35, no. 4, pp. 742-9, 2015.
2014
G. Mutua, Mutengu, L., Mpendo, J., Kilembe, W., Omosa, G., Ruzagirwa, E., Karita, E., Page-Shipp, L., Gray, G., Bekker, L. G., Barin, B., Schmidt, C., Laufer, D., and Priddy, F., “Major Negative Social Impacts are Rare in Phase 1 HIV Vaccine Trials in Africa”, in HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Cape Town, SA, 2014.
M. Eapen, O'Donnell, P., Brunstein, C. G., Wu, J., Barowski, K., Mendizabal, A., and Fuchs, E. J., “Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies.”, Biol Blood Marrow Transplant, vol. 20, no. 10, pp. 1485-92, 2014.
M. Eapen, O'Donnell, P., Brunstein, C. G., Wu, J., Barowski, K., Mendizabal, A., and Fuchs, E. J., “Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies”, Biol Blood Marrow Transplant, vol. 20, pp. 1485-1492, 2014.